1Considerations for the review of patient-focused development of antitumor drugsTANG Ling, ZHOU Ming, XIA Lin, TONG Xin, HAO Ruimin, ZHAO Xiao, SONG Yuanyuan, CHEN Dongmei, DU Yu, YANG ZhiminARTICLES577-5822Expression and prognostic value of glucose transporter 1 in patients with hepatocellular carcinomaZHENG Xia, ZHANG Yuanjing, GOU Yudong, WEI Qi, WEI Sihui, YANG Zhihui, QIN ShukuiARTICLES583-5893Expression and clinical significance of IL-6, STT3A and PD-L1 in gastric cancer tissuesTANG Jiaqi, HU Nan, WANG Huiyu, ZHANG Jingzhou, HONG Yidong, BIAN Baoxiang, SONG Ziyan, WU FengleiARTICLES590-5954The significance and expression of PFKP and CD133 in gastric cancerHU Pingping, CHEN Miao, SHAO Rui, XUE Di, MIAO ZhichengARTICLES596-6015Risk factors of postoperative lower limb lymphedema following lymphadenectomy in gynecologic malignanciesWANG Jianli, LI Zhuang, JIANG Lingling, YAO DeshengARTICLES602-6066Clinical study on optimization of sacral limit in IMRT for cervical cancerCHU Anhong, GUO Qi, CAI Shang, QIAN Jianjun, TIAN YeARTICLES607-6147Clinical observation of induction chrono-chemotherapy or adjuvant chrono-chemotherapy combined with cisplatin concurrent radiochemotherapy for locally advanced nasopharyngeal carcinomaSHU Hongbo, JIN Feng, WU Weili, LI Yuanyuan, LUO Xiuling, LONG Jinhua, GONG Xiuyun, CHEN Xiaoxiao, ZHAO Chaofen, HE Qianyong, LIU Lina, LI Zhuoling, BI TingARTICLES615-6218Construction and validation of a prognostic nomogram for children with rhabdomyosarcomaZHANG Lin, XIONG Hao, LI Jianxin, LI Hui, TAO Fang, WANG Zhuo, NIE Yingming, CHEN Zhi, TANG Wei, TENG JuxianARTICLES622-6289Clinical study of chloroquine in combination with cisplatin-based regimen as the first-line treatment for HER-2 negative advanced gastric cancerHE Bo, XIONG Shuping, SHEN Xiaohua, ZHONG Huaqiang, WAN Yiye, ZHANG HuiqingCLINICAL PRACTICE629-63210Analysis of the development trajectory of home functional exercise compliance in breast cancer patients after modified radical mastectomyCHU Xiaomin, XU Qin, LOU Ying, WANG Zijun, ZHANG YanCLINICAL PRACTICE633-63711Chinese Society of Clinical Oncology ( CSCO ) guidelines for standardized management of tumor chemoradiotherapy-related neutropenia ( Version 2021)Guidelines Committee of Chinese Society of Clinical OncologyGUIDELINE AND INTERPRETATION638-64812Advance on PD-1/PD-L1 and CTLA-4 immune checkpoint inhibitors in small cell lung cancerZHOU Jie, WU Qiang, XU Feng, DAI Shuang, ZHANG Hong'eREVIEWS AND LECTURES649-65613Research progress on exosomes in lung cancerHAN Ke, ZHANG YiREVIEWS AND LECTURES657-666 